If you have never used a peptide before, read the "How to Use This Chart" section first
Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
announced that approximately 14 of 19 previously restricted peptides - reportedly including BPC-157 - are expected to be moved back to Category 1 status, which would restore legal compounding pharmacy access
This blend is often explored for its potential to accelerate recovery from injuries, support joint health, and improve overall tissue regeneration, making it a subject of great interest in restorative and sports medicine
It can also be useful for treating burns, cuts, damaged skin
A 2 mg dose is 2 10 = 0.2 mL, which is 20 units on a U-100 insulin syringe